ADARx Pharmaceuticals, Inc. ADRX
13.84 USD -1.12 (-7.49%)
Nov 5, 2026, 2:03 PM EST
12.75 Day range 15.39
12.75 52-week range 23.21
- YTD
- -28.48%
- 1 year
- -28.48%
Held by funds
22 US ETFs and mutual funds hold ADRX · largest positions
Ownership
Held by insiders 41.78%
Held by institutions 49.16%
Float held by institutions 84.43%
Institutions 22
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Laurion Capital Management, LP | 0.02% | 20,000 | 298.40K | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 3.18% | 3,246,801 | 48.44M | Sep 29, 2026 |
| American Funds-SmallCap World Fund | 0.08% | 85,500 | 1.28M | Sep 29, 2026 |
| Federated Hermes Index Trust-Federated Hermes Max-Cap Index Fund | 0.00% | 225 | 3.36K | Sep 29, 2026 |
| Federated Hermes Index Trust-Federated Hermes Mid-Cap Index Fund | 0.00% | 220 | 3.28K | Sep 29, 2026 |
| Federated Hermes Income Securities TRT-Federated Hermes Muni and Stock | 0.00% | 2,089 | 31.17K | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHIMOVITS EREZ | Director | Purchase | Sep 27, 2026 | 0 |
| GEORGE SIMEON J. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
| GORDON CARL L | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
| LAV BIOSCIENCES FUND V LP | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 27, 2026 | 0 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
| SR ONE CAPITAL MANAGEMENT, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |